Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Albrecht

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Human Neuroscience|January 8, 2015
Neurofeedback of slow cortical potentials: neural mechanisms and feasibility of a placebo-controlled design in healthy adultsHolger Gevensleben, Björn Albrecht, Henry Lütcke, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|August 29, 2009
Distinct EEG effects related to neurofeedback training in children with ADHD: a randomized controlled trialHolger Gevensleben, Birgit Holl, Björn Albrecht, et al.
European Journal of Psychotraumatology|January 7, 2021
BEST FOR CAN - bringing empirically supported treatments to children and adolescents after child abuse and neglect: study protocolRita Rosner, Antonia Barke, Björn Albrecht, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 12, 2009
Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trialHolger Gevensleben, Birgit Holl, Björn Albrecht, et al.
Scientific Reports|June 21, 2017
Attention, cognitive control and motivation in ADHD: Linking event-related brain potentials and DNA methylation patterns in boys at early school ageHartmut Heinrich, Juliane Grunitz, Valeska Stonawski, et al.
Current Pharmaceutical Design|June 2, 2010
What can actigraphy add to the concept of labschool design in clinical trials?Henrik Uebel, Björn Albrecht, Roumen Kirov, et al.
Biological Psychology|August 20, 2021
Can neurophysiological markers of anticipation and attention predict ADHD severity and neurofeedback outcomes?Pascal-M Aggensteiner, Björn Albrecht, Ute Strehl, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 14, 2014
Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1Björn Albrecht, Daniel Brandeis, Henrik Uebel-von Sandersleben, et al.
Journal of Medical Internet Research|November 27, 2024
A Blended Learning Course on the Diagnostics of Mental Disorders: Multicenter Cluster Randomized Noninferiority TrialGabriel Bonnin, Svea Kröber, Silvia Schneider, et al.
NPJ Precision Oncology|March 26, 2026
Finding the most promising indications for novel treatments in oncologyMaren Eckhoff, Stefan Klingelschmitt, Lisbeth Van Ruijssevelt, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Human Neuroscience|January 8, 2015
Neurofeedback of slow cortical potentials: neural mechanisms and feasibility of a placebo-controlled design in healthy adultsHolger Gevensleben, Björn Albrecht, Henry Lütcke, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|August 29, 2009
Distinct EEG effects related to neurofeedback training in children with ADHD: a randomized controlled trialHolger Gevensleben, Birgit Holl, Björn Albrecht, et al.
European Journal of Psychotraumatology|January 7, 2021
BEST FOR CAN - bringing empirically supported treatments to children and adolescents after child abuse and neglect: study protocolRita Rosner, Antonia Barke, Björn Albrecht, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 12, 2009
Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trialHolger Gevensleben, Birgit Holl, Björn Albrecht, et al.
Scientific Reports|June 21, 2017
Attention, cognitive control and motivation in ADHD: Linking event-related brain potentials and DNA methylation patterns in boys at early school ageHartmut Heinrich, Juliane Grunitz, Valeska Stonawski, et al.
Current Pharmaceutical Design|June 2, 2010
What can actigraphy add to the concept of labschool design in clinical trials?Henrik Uebel, Björn Albrecht, Roumen Kirov, et al.
Biological Psychology|August 20, 2021
Can neurophysiological markers of anticipation and attention predict ADHD severity and neurofeedback outcomes?Pascal-M Aggensteiner, Björn Albrecht, Ute Strehl, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|February 14, 2014
Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1Björn Albrecht, Daniel Brandeis, Henrik Uebel-von Sandersleben, et al.
Journal of Medical Internet Research|November 27, 2024
A Blended Learning Course on the Diagnostics of Mental Disorders: Multicenter Cluster Randomized Noninferiority TrialGabriel Bonnin, Svea Kröber, Silvia Schneider, et al.
NPJ Precision Oncology|March 26, 2026
Finding the most promising indications for novel treatments in oncologyMaren Eckhoff, Stefan Klingelschmitt, Lisbeth Van Ruijssevelt, et al.
Pageof 5